-
Merck & Parexel Enter Pact - Analyst Blog
Thursday, January 13, 2011 - 10:45am | 458Merck & Co. Inc. (MRK) recently entered into an agreement with Parexel International Corporation (PRXL). Per the terms of the deal, Merck BioVentures (a division of Merck) will have access to Parexel's range of regulatory, strategic and clinical development planning capabilities for the...
-
Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2010
Thursday, January 13, 2011 - 9:03am | 143Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced preliminary revenue for the fourth quarter of 2010 of approximately $36.0 million, which implies fiscal 2010 revenue of approximately $123.5 million, or 10% organic annual growth. The Company's fourth quarter revenue estimate exceeds the...
-
BROOKFIELD ASST (BAM) - Profit Tracks
Thursday, January 13, 2011 - 8:01am | 588Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid....
-
BROOKFIELD ASST (BAM) - Profit Tracks
Thursday, January 13, 2011 - 1:00am | 588Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid....
-
Illumina Illuminates Results - Analyst Blog
Wednesday, January 12, 2011 - 7:31pm | 405Illumina Inc. (ILMN) has announced preliminary results for the fourth quarter and fiscal 2010. The company expects to report $260 million of revenues during the quarter, higher than the Zacks Consensus Estimate of $248 million. Moreover, revenues for the fiscal is expected to be around $901...
-
Illumina Illuminates Results - Analyst Blog
Wednesday, January 12, 2011 - 6:55pm | 405Illumina Inc. (ILMN) has announced preliminary results for the fourth quarter and fiscal 2010. The company expects to report $260 million of revenues during the quarter, higher than the Zacks Consensus Estimate of $248 million. Moreover, revenues for the fiscal is expected to be around $901...
-
Covance Shares Up 7.5% (CVD)
Wednesday, January 12, 2011 - 4:50pm | 128Shares of Covance Inc. (NYSE: CVD) are trading up 7.5% at $55.57 per share during the Wednesday afternoon trading session. The day's range for shares of Covance Inc has been between $52.01 and $56.23 per share. The average price target of analysts who cover Covance Inc. (CVD) is $50.20 per share....
-
Affymetrix Soars 14.3% On Guidance (AFFX)
Wednesday, January 12, 2011 - 3:27pm | 223Shares of Affymetrix, Inc. (Nasdaq: AFFX) are trading up 14.3% at $5.36 per share during the Wednesday afternoon trading session. The company reported on Wednesday before the market opened that it expects to earn a profit during the 4th quarter, on revenue of about $85 million. President and chief...
-
Piper Jaffray Reiterates Overweight Rating on Sequenom (SQNM)
Wednesday, January 12, 2011 - 2:36pm | 152Piper Jaffray is out with a research report this morning, where it reiterates its Overweight rating on Sequenom (NASDAQ: ILMN); it has an $8.50 price target on the stock, up from $8.00. The Piper Jaffray analysts cited a recent publication of Dr. Dennis Lo's study of 753 pregnant women at high...
-
Auriga Reiterates Buy Rating on Illumina Inc. (ILMN)
Wednesday, January 12, 2011 - 2:31pm | 160Auriga is out with a research report this morning, where it reiterates its Buy rating on Illumina Inc. (NASDAQ: ILMN); it has a $75.00 price target on the stock. The Auriga analysts cited the company's recent pre-announcement of earnings, which topped estimates. Initial 2011 guidance appears...
-
Wednesday's Put/Call Ratio Leaders (RRD, AMAG, WMB, AGO, AIXG)
Wednesday, January 12, 2011 - 1:55pm | 94Here is a quick peek at stocks that have abnormally high daily put/call ratios today relative to their average…. 1. R.R. Donnelley & Sons (NYSE: RRD) 3,109 puts, 82 calls 2. AMAG Pharmaceuticals (NASDAQ: AMAG) 4,657 puts, 175 calls 3. Williams Companies (NYSE: WMB) 26,357 puts, 2,107 calls 4....
-
Options Brief: AMAG Pharmaceuticals (AMAG)
Wednesday, January 12, 2011 - 1:40pm | 90Shares of AMAG Pharmaceuticals (NASDAQ: AMAG) are lower on the session by 0.22%, trading at $18.19. Overall put volume is now running at 17.87x the daily average, with 6% of all puts traded being purchases on the offer. 3,752 contracts have traded on the session so far. AMAG Pharmaceuticals, Inc....
-
Goldman Sachs Comments On Illumina & Reiterates Its Buy Rating
Wednesday, January 12, 2011 - 11:31am | 187Illumina (NASDAQ: ILMN) pre-announced 4Q10 revenue of approximately $260 mn, ahead of the Street at $249 mn and in line with Goldman $259 mn estimate. However, EPS of $0.28-$0.29 fell short of Goldman/Street estimates of $0.33/$0.33. Guidance for 2011 was for approximately 20% growth, a 70% gross...
-
Morning Market Movers (SDIX, ZLC, GFN, ITT)
Wednesday, January 12, 2011 - 11:20am | 158Strategic Diagnostics Inc (NASDAQ: SDIX) jumped 46.77% to $2.73 at 10:15 am. SDIX's RapidChek SELECT Salmonella Enteritidis (SE) test system has been considered by US Food and Drug Administration (FDA) as equivalent to its standard test. Zale Corporation (NYSE: ZLC) shares surged 34.24% to $5.41....
-
Short Interest Slides on Healthcare Names (DNEX, BEC, PLL)
Wednesday, January 12, 2011 - 10:38am | 224Jefferies & Company is out with a research report this morning, where it notes that median short interest for Diagnostic and Research Supplies stocks fell 1% and 7%, respectively, in the second half of December. This compares to a 5% absolute decline for both the NYSE and NASDAQ. Short interest...